A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate efficacy and safety of tacrolimus in the patients with
non-nephrotic albuminuric, normotensive IgA nephropathy after 16 week treatment with
tacrolimus (Prograf) or placebo.